drugset / Trial / NCT00567047
Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the pharmacokinetics of vildagliptin and its metabolites in patients with mild, moderate or severe renal impairment and healthy volunteers.
Timeline
- Start
- 2007-07
- Primary completion
- 2009-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vildagliptin | Other / unclassified | 50 mg | — |